Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ANGH | Anghami | $3.84 | $1.52 | 65.52% | 40.7M | $16M | $2.25$8.40 |
| ESHA | Esh Acquisition Corp. | $21.70 | $7.32 | 50.90% | 7.2M | $56M | $10.76$27.00 |
| SIDU | Sidus Space | $3.59 | $0.92 | 34.46% | 110.5M | $94M | $0.63$3.75 |
| VNDA | Vanda Pharmaceuticals | $9.04 | $2.01 | 28.59% | 380.5K | $415M | $3.81$9.60 |
| ULY | Urgent.ly | $3.53 | $0.77 | 27.90% | 13.7M | $6.0M | $1.74$17.99 |
| AXSM | Axsome Therapeutics | $183.70 | $34.91 | 23.46% | 100.4K | $7.5B | $79.19$184.25 |
| BENF | Beneficient | $7.11 | $1.35 | 23.44% | 178K | $81M | $1.75$12.48 |
| BCG | Binah Capital Group | $3.16 | $0.50 | 18.80% | 83.5K | $44M | $1.36$5.81 |
| BYFC | Broadway Financial | $7.10 | $1.09 | 18.14% | 93.1K | $55M | $5.51$9.46 |
| AEI | Alset | $3.23 | $0.49 | 17.88% | 105.3K | $107M | $0.70$4.55 |
Related Articles
Featured Article
2 Under-the-Radar Stocks to Buy Heading Into 2026
Prosper Junior Bakiny|Dec 1, 2025
These drugmakers are poised to profit from their innovative engines.
Should You Invest in This Under-the-Radar Weight Loss Stock?
Prosper Junior Bakiny|Nov 30, 2025
This small-cap drugmaker just soared on positive clinical trial data, but should you jump on the bandwagon?
Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years
Prosper Junior Bakiny|Sep 30, 2025
Both should have significant catalysts by the end of the decade.
Advertisement
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Yes, bargains can still be found in the stock market.
1 Under-the-Radar Biotech Stock to Buy and Hold
Prosper Junior Bakiny|Sep 29, 2024
It could be an industry giant in the making.
Should You Buy This Sinking Stock on the Dip?
Prosper Junior Bakiny|Jun 27, 2024
The biotech isn't having the best year.
Prediction: These 2 Growth Stocks Could Triple By 2030
Prosper Junior Bakiny|May 11, 2024
These companies have a habit of silencing the bears.
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
The price could be right for these three biopharma stocks.
These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?
Sushree Mohanty|Aug 24, 2023
Today's market loser could be tomorrow's market winner.
